- Home
- MGPI vs CLLS Comparison
MGPI vs CLLS Comparison
Compare MGPI & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGPI | CLLS |
|---|---|---|
| Founded | 1941 | 1999 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.4M | 476.5M |
| IPO Year | 1988 | 2007 |
Fundamental Metrics
Financial Performance| Metric | MGPI | CLLS |
|---|---|---|
| Price | $24.88 | $4.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $33.25 | $8.50 |
| AVG Volume (30 Days) | ★ 390.0K | 79.2K |
| Earning Date | 02-25-2026 | 03-12-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $578,855,000.00 | $82,551,000.00 |
| Revenue This Year | N/A | $32.58 |
| Revenue Next Year | N/A | $20.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 129.04 |
| 52 Week Low | $21.67 | $1.10 |
| 52 Week High | $38.11 | $5.48 |
Technical Indicators
Market Signals| Indicator | MGPI | CLLS |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 40.94 |
| Support Level | $23.05 | $3.93 |
| Resistance Level | $25.18 | $4.17 |
| Average True Range (ATR) | 0.74 | 0.23 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 77.80 | 16.83 |
Price Performance
Historical ComparisonAbout MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.